Product Information
BETIMOL 0.5% EYE DROPS is a brand product labeled by Thea Pharma Inc., priced at $31.1223 per ML under NDC 82584000205. Its NADAC has been published 168 times since Jul 19, 2023.
FDA first approved this application on Mar 31, 1995. Its Orange Book therapeutic-equivalence code is AT.
Strength
5.12 mg/mL
Manufacturer
Thea Pharma Inc.NDC
82584000205
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
2/18/2026
Active Ingredients
TIMOLOLApproval Type
New Drug (NDA)
FDA Application
NDA020439FDA Approved
3/31/1995
TE Code
AT
On Market Since
11/15/2022
Pharmacological Classes
Price Statistics
The NADAC for BETIMOL 0.5% EYE DROPS has been published 168 times since Jul 19, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.1223 per ML |
|---|---|
| All-time high | $31.3603 (Dec 11, 2024) |
| All-time low | $31.0625 (Dec 17, 2025) |
| 52-week high | $31.2177 |
| 52-week low | $31.0625 |
| Median price | $31.3061 |
| Average price | $31.2553 |
| Largest weekly change | +0.3% (Jan 21, 2026) |
| Weeks tracked | 168 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the timolol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Thea Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
timolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETIMOL 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BETIMOL 0.5% EYE DROPS, manufactured by Thea Pharma Inc., is $31.1223 per ML (NDC 82584000205), effective Sep 30, 2026.
How has the price of BETIMOL 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BETIMOL 0.5% EYE DROPS has held within roughly two percent of its current level. It has been tracked across 168 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for BETIMOL 0.5% EYE DROPS?
Since Jul 19, 2023, the NADAC for BETIMOL 0.5% EYE DROPS has ranged from a low of $31.0625 (Dec 17, 2025) to a high of $31.3603 (Dec 11, 2024), with a median of $31.3061 per ML.
Are there cheaper alternatives to BETIMOL 0.5% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of BETIMOL 0.5% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BETIMOL 0.5% EYE DROPS?
BETIMOL 0.5% EYE DROPS (NDC 82584000205) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.